Aligos Therapeutics, Inc. (ALGS) News
Follow Aligos Therapeutics, Inc. (ALGS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Lobo Technologies Ltd (NASDAQ: LOBO ) rose sharply in pre-market trading after the company reported a year-over-year increase in H1 financial results. Lobo EV Technologies posted a H1 loss of 7 cents per share,
LIVE | Sep 21, 2026, 09:01 AM UTC
L
ALGS: Pevy and ASO-675 advance as synergistic HBV therapies, aiming to expand functional cure rates
The session highlighted novel HBV therapies targeting unmet needs, with pevy showing multi-pathway inhibition and superior potency in ongoing phase II trials. ASO-675, developed with Amoytop, advances rapidly in China an
GEOPOLITICS | Sep 09, 2026, 08:15 PM UTC
L
ALGS: Pevifoscorvir and a novel ASO program aim to expand HBV functional cure rates through innovative mechanisms
The session highlighted novel HBV therapies addressing unmet needs beyond current nucleoside analogues and ASOs. Pevifoscorvir targets multiple HBV life cycle steps and shows promise in ongoing phase II trials, while a n
EQUITY | Sep 09, 2026, 07:37 PM UTC
L
Aligos Therapeutics to present at Cantor Global Healthcare Conference
Aligos Therapeutics announced management will present at the Cantor Global Healthcare Conference, according to a GlobeNewswire release.
EQUITY | Sep 02, 2026, 12:07 PM UTC
L
ALGS - Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
ALGS - Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
EQUITY | Sep 02, 2026, 12:00 PM UTC
L
Aligos Therapeutics Doses First Participant
Aligos Therapeutics announces first participant dosed in Phase 1 study of ALG-170675
EQUITY | Aug 12, 2026, 08:07 PM UTC
L
ALGS - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
ALGS - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
EARNINGS | Aug 06, 2026, 12:01 PM UTC
L
ALGS - Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
ALGS - Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
EARNINGS | Jul 30, 2026, 12:00 PM UTC